Sep 22, 2026 7 0
Uploaded by Ivy
Favorite
Share
More Options
26
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses_Page 1

Open in WPS to view all 26 pages